Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of CRISPR Therapeutics in a research report issued on Tuesday, January 21st. Cantor Fitzgerald ...

As health secretary, RFK Jr. said he would divest interests in several companies—including CRISPR Therapeutics and Dragonfly ... letter filed with the U.S. Office of Government Ethics.

Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...

When Foss arrived as a postdoc in 2017, her research focused on how to use proteins as therapeutics inside of cells, helping to develop a way to deliver CRISPR enzymes. The key, combining the ...

HHS Secretary designate Robert F. Kennedy Jr. earned $326,000 from the anti-vaccine group Children's Health Defense and a $100,000 licensing fee for use of the Make America Healthy Again brand, ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...

President Trump says the the 30,000-person facility for undocumented migrants will house "the worst criminal illegal aliens".

Duke University cancer researcher Prof Donald McDonnell on BTYSTE and how learning the scientific process at an early age is ...

Robert F. Kennedy Jr. earned millions from his work as an attorney, including referral fees from cases filed against the agency he’s been chosen to lead, federal disclosures show.

Source: Office of Government Ethics RFK Jr. bought BTC in May ... appear to extend to gene editing — as the filing reveals a $1,001 to $15,000 stake in CRISPR Therapeutics AG (NASDAQ: CRSP).